Search

everythinglearnresearchcommunity

for

Search:↓

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Hidradenitis suppurativa is linked to various diseases like obesity, depression, arthritis, and Crohn's disease, but often occurs alone.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

People with alopecia areata may have a higher risk of thyroid diseases.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

People with autism are more likely to develop alopecia areata than those without autism.

SLE is likely one disease with various symptoms, not multiple distinct diseases.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

Hypothyroidism may cause certain types of hair loss.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Celiac disease can cause thyroid medication malabsorption, and a gluten-free diet can help stabilize thyroid levels.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Alopecia areata may be linked to kidney issues, but more research is needed.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Genetic differences affect how people respond to COVID-19.

Higher levels of certain proteins may increase or decrease rosacea risk.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Scalp seborrheic dermatitis is a common skin condition linked to oil production and bacteria, with specific diagnostic features and treatments like antifungals and corticosteroids.

A mutation in the IL2RA gene increases the risk of alopecia areata.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

People with Alopecia Areata are more likely to have prediabetes and obesity.

New understanding and treatments for hair loss are improving, but more research is needed.

Dental care may help improve hair loss in alopecia patients.